HitGen LTD:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HitGen LTD - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11216
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HitGen LTD (HitGen) is a drug company that concentrates on hit identification and lead generation in the early phases of drug discoveries and development. The company provides OpenDEL, a collection of DNA encoded library compounds based on distinct, diverse and drug structures. It offers biological reagents, edge technology and services for progression of projects and services. HitGen provides services such as lead generation by DNA encoded chemical libraries; hit to lead expansion and lead optimization; custom compound and compound library synthesis and others. The company’s research support capabilities comprise protein expression and purification, chemical library design and synthesis, in-vitro screening and affinity selection, among others. It caters contract research organizations and pharmaceutical industries. HitGen is headquartered in Chengdu, China.

HitGen LTD – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen LTD, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
HitGen Raises USD39.1 Million in Series B Venture Financing 11
Partnerships 12
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Licensing Agreements 25
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD – Key Competitors 29
HitGen LTD – Key Employees 30
HitGen LTD – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Government and Public Interest 32
Aug 03, 2018: HitGen launching initiative to discover new medicines to combat tuberculosis and malaria 32
Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
HitGen LTD, Pharmaceuticals & Healthcare, Key Facts 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Deals By Therapy Area, 2012 to YTD 2018 8
HitGen LTD, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HitGen Raises USD39.1 Million in Series B Venture Financing 11
HitGen Enters into Research Agreement with LG Chem Life Sciences 12
HitGen Enters into Research Collaboration Agreement with Sanofi 13
HitGen Enters into Research Agreement with Boehringer Ingelheim 14
HitGen Enters into Agreement with Takeda Pharma 15
Cocrystal Pharma Enters into Research Agreement with HitGen and InterX 16
HitGen Enters into Agreement with Aduro Biotech 17
HitGen Enters into Research Agreement with LEO Pharma 18
HitGen Enters into Partnership with Scripps Research Institute and California Institute for Biomedical Research 19
HitGen Expands Agreement with Merck 20
HitGen Enters into Agreement with Janssen Biotech 21
HitGen Enters into Research Agreement with Global Blood Therapeutics 22
HitGen Enters into Drug Discovery Agreement with Cancer Research UK and Cancer Research Technology 23
HitGen Enters Into Distribution Agreement With Tecrea For HappyFect And NanoCargo 24
Forma Therapeutics and HitGen Enter into Licensing Agreement 25
HitGen Enters into Licensing Agreement with Simcere Pharma 26
Pfizer Enters into Licensing Agreement with HitGen 27
Cancer Research UK and Cancer Research Technology Enter into Licensing Agreement with HitGen 28
HitGen LTD, Key Competitors 29
HitGen LTD, Key Employees 30
HitGen LTD, Subsidiaries 31

List of Figures
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HitGen LTD, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HitGen LTD, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HitGen LTD:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ablynx NV (ABLX)-製薬・医療分野:企業M&A・提携分析
    Summary Ablynx NV (Ablynx) is a clinical-stage biopharmaceutical company focused on the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. Nanobodies are a novel class of antibody-derived therapeutic proteins which possess structural and functional …
  • InterGen:企業の戦略的SWOT分析
    InterGen - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Lee’s Pharmaceutical Holdings Ltd (950):企業の財務・戦略的SWOT分析
    Summary Lee's Pharmaceutical Holdings Ltd (Lee's Pharmaceutical) is a biopharmaceutical company that offers development of novel therapies and contract research services. The company provides products in the treatment of disease areas such as urology, cardiovascular oncology, dermatology, hematology …
  • MetaStat Inc (MTST):医療機器:M&Aディール及び事業提携情報
    Summary MetaStat Inc (MetaStat) is a biotechnology company that discovers and develops personalized diagnostic and therapeutic treatment solutions for cancer patients. The company develops therapeutic product candidates based on novel approach that offers intracellular Mena protein isoforms drugable …
  • Deloitte Touche Tohmatsu Ltd:企業の戦略的SWOT分析
    Deloitte Touche Tohmatsu Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Johnson & Johnson (JNJ)-医療機器分野:企業M&A・提携分析
    Summary Johnson & Johnson (J&J) engages in the research and development, manufacture and sale of a range of healthcare products. Its primary focus is on the development of products related to human health and well-being. The company provides pharmaceuticals in immunology, cancer, neuroscience, infec …
  • James Cropper PLC (CRPR):企業の財務・戦略的SWOT分析
    James Cropper PLC (CRPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Astrapak Limited (APK):企業の財務・戦略的SWOT分析
    Astrapak Limited (APK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Expanesthetics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Expanesthetics Inc (Expanesthetics) is a developer of anesthetic and analgesic agents. The company develops inhalation anesthetic agents used in surgical procedures. It offers CNS drug development programs for various types of pains and indications such as post-operative pain, traumatic inju …
  • The Ultimate Software Group Inc (ULTI):企業の財務・戦略的SWOT分析
    The Ultimate Software Group Inc (ULTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • One Lambda Inc-医療機器分野:企業M&A・提携分析
    Summary One Lambda Inc (One Lambda), a subsidiary of Thermo Fisher Scientific Inc is a medical device company that offers laboratory products. The company develops and distributes histocompatibility typing tests and antibody detection products. Its products include HLA tissue typing trays, HLA testi …
  • HepQuant Llc:企業の製品パイプライン分析2018
    Summary Hepquant LLC (Hepquant) is a medical device company that offers diagnostic products. The company develops and markets patented and patent-pending technology for assessing liver function of patients with chronic liver disease. It offers investigational combination drug and diagnostic devices. …
  • Investigator Resources Ltd (IVR):企業の財務・戦略的SWOT分析
    Summary Investigator Resources Ltd (Investigator Resources), is a mining company that offers exploration and development of mineral properties. The company acquires, explores and develops precious and base metal assets in Eyre Peninsulas of South Australia. It operates projects such as Paris Silver …
  • BioCardia Inc:製品パイプライン分析
    Summary BioCardia Inc (BioCardia) is a clinical-stage regenerative medicine company that develops novel therapeutics for cardiovascular diseases. The company develops biotherapeutic candidate, which include CardiAMP cell therapy system, an autologous minimally processed bone marrow cells; and CardiA …
  • BellBrook Labs LLC-医療機器分野:企業M&A・提携分析
    Summary BellBrook Labs LLC (BellBrook) is a medical device company that develops detection reagents and screening tools. The company’s biochemical assay technology offers UVO microconduit array platform, chemotaxis assay plate, transcreener HTS assays, ADP² assays, AMP² and GMP² assays, GDP assays, …
  • Main Line Health System:企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Perseus Mining Ltd:企業の戦略・SWOT・財務分析
    Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report Summary Perseus Mining Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lanco Infratech Ltd:発電所・企業SWOT分析
    Lanco Infratech Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆